ImmunityBio
IBRX
6.02
-0.55
-8.37%
ImmunityBio
US · IBRX
#1397 by market cap
Listed 1970
6.02
-0.55
-8.37%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:59
About ImmunityBio
ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.
- Founded
- 2014
- CEO
- Mr. Richard Adcock
- Employees
- 691
- Headquarters
- San Diego, California, United States of America
- Fiscal year end
- 12-31
- Website
- immunitybio.com
Company profile
- Exchange
- US
- Symbol
- IBRX
- Market-cap rank
- #1397
- Listing date
- 1970-01-01
- Market cap
- 6.40B
- Float cap
- 2.47B
- Shares out
- 1.06B
- Float shares
- 410.68M
Sectors & themes
Quote time 2026-11-20 19:59:40 · For reference only, not investment advice and not tailored to your situation.
ImmunityBio discussion 0 comments